Serialization/Aggregation - Live Online Training Dealing with different global requirements
Kurs Nr. 19503
This course is part of the GMP Certification Programme "ECA Certified Packaging Manager". Learn more.
Note: All times mentioned are CET.
Unser Seminarservice
Kosten
Dieses Seminar/Webinar kann nicht gebucht werden. Alternative Termine für dieses Seminar/Webinar und ähnliche Veranstaltungen finden Sie in der Liste aller GDP Seminare.
Für viele Seminare und Webinare gibt es auch Aufzeichnungen, die Sie jederzeit bestellen und anschauen können. Diese Aufzeichnungen finden Sie hier.
Oder senden Sie uns Ihre Anfrage einfach über das folgende Kontaktformular.
* auch unkompliziert per Kreditkarte bezahlbar
Rückfragen unter:
Tel.: 06221 / 84 44 0 E-Mail: info@concept-heidelberg.de
Speakers
Margarita Belichovska, EMVO, Belgium
Dr Ulrich Kissel, EQPA, Germany
Martin Kühn, Meliscout, Germany
Dieter Mößner, Packaging Expert, Germany
Dr Laura Ribeiro, OCP, Portugal
Michael Rowe, TwoLabs, USA
Dr Franz Schönfeld, GMP Inspector, Germany
Dr Stephan Schwarze, Bayer, Germany
Wilfried Weigelt, REA Elektronik, Germany
Dr Ulrich Kissel, EQPA, Germany
Martin Kühn, Meliscout, Germany
Dieter Mößner, Packaging Expert, Germany
Dr Laura Ribeiro, OCP, Portugal
Michael Rowe, TwoLabs, USA
Dr Franz Schönfeld, GMP Inspector, Germany
Dr Stephan Schwarze, Bayer, Germany
Wilfried Weigelt, REA Elektronik, Germany
Objectives
It is the course’s goal to inform about the latest developments regarding the compliance with the Falsified Medicines Directive 2011/62/EU and its Delegated Regulation EU 2016/161. Best practice examples will demonstrate how the requirements on verification of the authenticity of each single medicinal product can be fulfilled and false alerts can be managed efficiently. In addition, global aspects, like aggregation and the different types of coding will be covered.
Background
Since 9th of February 2019 the Commission Delegated Regulation applies. With it the detailed rules for safety features on the packaging of medicinal products for human use are in place and need to be followed. Frequently updated Question and Answer documents have been published in addition to provide guidance. Moreover three Aide Memoires have been published for::
- GMP INSPECTIONS OF MANUFACTURERS,
- GDP INSPECTIONS OF WHOLESALERS,
- INSPECTIONS OF PHARMACIES
COMPLIANCE WITH COMMISSION DELEGATED REGULATION (EU) 2016/161 FOR SAFETY FEATURES.
More than three years in the operational phase of the EU Verification System a significant number of manufacturers and supply chain actors have still not connected to the system.
In addition, the Industry is still fighting with false alerts and most of the member states are still in stabilization phases. Scans undertaken by supply chain actors often lead to false alerts being generated due to various reasons, such as:
In addition, the Industry is still fighting with false alerts and most of the member states are still in stabilization phases. Scans undertaken by supply chain actors often lead to false alerts being generated due to various reasons, such as:
- Missing data upload into the European Hub,
- Incorrect data upload,
- Incorrect scanner configuration of end-users,
- Pharmacy / hospital software systems not updated,
- Procedural reasons,
- System not used properly.
This Live Online Training Course will support you in collecting, sorting and proper understanding of the relevant requirements related to the defined safety features..
Practical examples will be presented and further discussed in corresponding Q&A sessions during this Live Online Training Course dealing with questions like:
Practical examples will be presented and further discussed in corresponding Q&A sessions during this Live Online Training Course dealing with questions like:
- What are the challenges of the EU delegated regulation for safety features the supply chain actors are currently facing?
- What are the weak points of the current End-to-End verification System?
- Will aggregation soon be required in the EU?
- What are the requirements regarding serialization / aggregation on a global level?
- How to deal with the different global requirements in practice?
- How could a best practice process of suspected falsified medicines handling may look like?
- Do we need a new alert management system or will we use established quality systems?
- What to do if a real falsification is the most likely conclusion?
Target Group
Executive and operational managers of all actors of the supply chain (e.g. manufacturers, pharmacies, hospitals, wholesalers, dispensing doctors), as well as IT and engineering staff, responsible for the implementation or operation of the new systems are the target group of this event.
The topics provided are also of interest for QA personnel dealing with alerts and complaints, QPs, suppliers of packaging (and authentication technology), and GMP/GDP Inspectors.
The topics provided are also of interest for QA personnel dealing with alerts and complaints, QPs, suppliers of packaging (and authentication technology), and GMP/GDP Inspectors.
Technical Requirements
We use Webex Events for our live online training courses and webinars. At https://www.gmp-compliance.org/training/online-trainingtechnical- information you will find all the information you need to participate in our events and you can check if your system meets the necessary requirements to participate. If the installation of browser extensions is not possible due to your rights in the IT system, please contact your IT department. Webex is a standard nowadays and the necessary installation is fast and easy.
Programme
Programme Day 1 - EU View
Delegated Regulation – Serialization & Anti-Tampering Device – What’s in?
- Overview and context
- Requirements as defined in the Delegated Regulation
- What can be expected next?
Serialization - The Inspector’s View
- Regulatory expectations
- Roles and responsibilities for implementation, maintenance, data upload & release
- Current issues: connections, false alerts
Q&A Session 1
Update of the EMVO
- Readiness and lessons learned of the European supply chain stakeholders
- Development of (false) alerts
- Stabilization periods across Europe
- Enforcement and inspections by National Competent Authorities
Serialization - Experience on the Wholesaler Scope
- How to deal with suspected and confirmed falsified medicines
- Who should manage communication with the end users
- Current issues
Handling of Alerts / Deviations / Complaints/ Falsifications
- Do we need a new alert management system or will we use established quality systems?
- Is a modification of deviation management required?
- Safety features and Serialization: How do they impact our complaint management systems?
- What to do if real falsification is the most likely conclusion?
The Perspective of the Qualified Person
- Impact of safety features and serialization on certification
- Data, data management and QPs
- QPs facing too many alerts
- The QP´s wish list on serialization
Q&A Session 2
Programme Day 2 - Global View
Track & Trace: Aggregation with Folding Boxes, Bundles, Outer Packaging, Pallets
- Current requirements in Turkey, EU, France, Brazil etc.
- Practical examples of Track & Trace Systems (from Folding Boxes to Pallets)
Coding: Russian KryptoCode/ Japan & Others
- Requirements & Practical Examples
- Printing, Coding & Control
- Scanning
Serialization – Industry’s Perspective
- Implementation challenges (EU)
- Current Status (EU)
- Expectations & Global Challenges: Canada, Russia, Ecuador
Q&A Session 3
Track & Trace in the US
- Introduction to DSCSA
- Upcoming DSCSA Requirements for serialized data exchange
Global View: Focus on Russia and Brazil
- Russian Serialization requirements
- Implementation and technical challenges
- Outlook on extension to additional products
- Brazilian Serialization requirements
- Serialization, aggregation and commissioning requirements
- Outlook – who’s next?
Q&A Session 4